The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAllergy Thera. Share News (AGY)

Share Price Information for Allergy Thera. (AGY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.25
Bid: 5.20
Ask: 5.30
Change: 0.00 (0.00%)
Spread: 0.10 (1.923%)
Open: 5.20
High: 5.30
Low: 5.20
Prev. Close: 5.25
AGY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Wed, 26th Feb 2020 16:15

Thursday 27 February 
Standard CharteredFull Year Results (at 0415 GMT)
WPP Full Year Results
Flutter EntertainmentFull Year Results
Watches of SwitzerlandTrading Statement
Aston Martin LagondaFull Year Results
RSA Insurance GroupFull Year Results
WPP Full Year Results
Reckitt BenckiserFull Year Results
PersimmonFull Year Results
MondiFull Year Results
Rentokil InitialFull Year Results
St James's PlaceFull Year Results
British American TobaccoFull Year Results
InchcapeFull Year Results
Grafton GroupFull Year Results
NetcallHalf Year Results
PPHE HotelsFull Year Results
Playtech Full Year Results
Macfarlane GroupFull Year Results
Haydale GrapheneHalf Year Results
Hikma Pharmaceuticals Full Year Results
FBD HoldingsFull Year Results
Georgia CapitalFull Year Results
Drax GroupFull Year Results
Provident FinancialFull Year Results
Vistry GroupFull Year Results
VesuviusFull Year Results
RicardoFull Year Results
EvrazFull Year Results
National ExpressFull Year Results
Amigo HoldingsFull Year Results
GenusFull Year Results
HuntingFull Year Results
James Fisher & SonsFull Year Results
Hastings Group HoldingsFull Year Results
Howden Joinery GroupFull Year Results
BakkavorFull Year Results
Verona PharmaFull Year Results
Base ResourcesFull Year Results
Friday 28 February 
London Stock Exchange GroupFull Year Results
International Consolidated Airlines GroupFull Year Results
CRHFull Year Results
RightmoveFull Year Results
Rolls-Royce HoldingsFull Year Results
Glenveagh PropertiesFull Year Results
Surface TransformsHalf Year Results
Vitec Full Year Results
EssentraFull Year Results
Tetragon Financial GroupFull Year Results
IMIFull Year Results
Man GroupFull Year Results
FoxtonsFull Year Results
ConvaTec GroupFull Year Results
Jupiter Asset ManagementFull Year Results
Monday 2 March 
Johnson Service GroupFull Year Results
Greencoat RenewablesFull Year Results
HiscoxFull Year Results
Mid Wynd International Investment TrustHalf Year Results
SeniorFull Year Results
Tuesday 3 March 
IntertekFull Year Results
John Laing GroupFull Year Results
XP PowerFull Year Results
4imprint GroupFull Year Results
Cairn HomesFull Year Results
FresnilloFull Year Results
Ashtead GroupQ3 Results
Hutchison ChinaFull Year Results
Direct Line InsuranceFull Year Results
Greggs Full Year Results
HuntsworthFull Year Results
Travis PerkinsFull Year Results
GoCo GroupFull Year Results
DX GroupHalf Year Results
Robert WaltersFull Year Results
RotorkFull Year Results
KellerFull Year Results
Apax Global AlphaFull Year Results
CranewareHalf Year Results
IbstockFull Year Results
International Game TechnologyQ4 Results
IWGFull Year Results
Wednesday 4 March 
BATM AdvancedFull Year Results
Allergy TherpeutucsHalf Year Results
Hostelworld GroupFull Year Results
Mpac GroupFull Year Results
Crystal Amber FundHalf Year Results
Vivo EnergyFull Year Results
Legal & GeneralFull Year Results
Polymetal InternationalFull Year Results
TT ElectronicsFull Year Results
BiffaTrading Statement
Hill & Smith HoldingsFull Year Results
ElementisFull Year Results
  
Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
7 Dec 2015 07:54

Allergy Therapeutics Begins US Phase II Study Of Grass Allergy Vaccine

Read more
30 Nov 2015 09:25

Allergy Therapeutics Completes Patient Enrolment For Birch Study

Read more
17 Nov 2015 14:36

Allergy Therapeutics raises £12m to develop peanut and dust mite treatments

(ShareCast News) - Shares in Allergy Therapeutics fell as, despite a strong trading update, the company launched a £12m discounted fundraising to speed development of treatments for peanut allergy and house dust mites allergies. The AIM-listed company completes the institutional placing by mid-after

Read more
17 Nov 2015 13:03

UPDATE: Allergy Therapeutics Raises GBP11.5 Million To Fund Growth (ALLISS)

Read more
17 Nov 2015 10:14

Allergy Therapeutics To Raise GBP12 Million To Fund Growth (ALLISS)

Read more
16 Nov 2015 16:37

AGM, EGM Calendar - Week Ahead

Read more
4 Nov 2015 10:43

Allergy Therapeutics To Present Adjuvant Data At Spain Conference

Read more
13 Oct 2015 08:43

BROKER RATINGS SUMMARY: Citi Cuts AB Foods As UBS Raises Smiths Group

Read more
21 Sep 2015 08:11

Allergy Therapeutics Says Outlook "Very Positive" As Profit Falls

Read more
14 Sep 2015 14:58

Earnings, Trading Statements Calendar - Week Ahead

Read more
1 Sep 2015 08:35

Allergy Therapeutics Enrols First Patient For Birch Drug Study

Read more
10 Aug 2015 07:23

Allergy Therapeutics Says Paper Published In World Allergy Journal

Read more
27 Jul 2015 16:58

Allergy Technologies' chief executive buys 50,000 shares

(ShareCast News) - The chief executive of Allergy Therapeutics bought new shares in the company few days after releasing a positive trading update. Manuel Llobet purchased 50,000 shares for an individual price of 24.45p, spending a total of £12,225. After the transaction, Llobet holds 3.175m shares

Read more
27 Jul 2015 16:24

DIRECTOR DEALINGS SUMMARY: New MySale Chairman Buys 60,000 Shares

Read more
27 Jul 2015 11:37

DIRECTOR DEALINGS: Allergy Therapeutics CEO Buys 50,000 Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.